Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.70%
SPX
+0.07%
IXIC
+0.18%
FTSE
+0.85%
N225
-0.61%
AXJO
-0.46%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

DARE missed EPS expectations by 100.00%

Aug 21, 2024, 9:35 AM
0.00%
What does DARE do
Daré Bioscience, Inc., a healthcare company based in San Diego, specializes in developing and commercializing pharmaceuticals for women's reproductive health, including products like XACIATO for bacterial vaginosis. The company, which launched its IPO in 2014, has a range of products in development, such as Ovaprene, a hormone-free contraceptive, and Sildenafil Cream for female sexual arousal disorder.
Dare Bioscience (DARE) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Dare Bioscience's actual EPS was -$0.88, missing the estimate of $0.00 per share, resulting in a -100.00% surprise.
📡️ Health Care
Earnings Surprise

More Signals

Feature in Progress
This section is under development. Check back soon for updates!